FIRESIDE CHAT: Driving ROI in Clinical Trials with Real-World Data Innovation

About this session

Brigham Hyde and a pharmaceutical partner will reveal how real-world data is transforming clinical development, enabling faster, smarter decisions that reduce costs and time-to-market. By leveraging these data assets for rapid hypothesis testing, protocol optimization, and regulatory alignment, this innovation not only accelerates drug development but also offers a significant return on investment. Investors will gain insights into how these advancements create a competitive advantage in the evolving clinical trials landscape.

Speakers

• 

  David Apfel

  Executive Director, Head, External Innovation, R&D Data Science and Digital Health · Johnson & Johnson

  Speaker

• 

  Brigham Hyde

  CEO, Atropos Health & Venture Partner, Audere Capital LLC · Atropos Health

  Moderator